Date lodged: 5 October 2016
To ask the Scottish Government what its position is on the use of the medicine, Sativex, in the NHS.
Answered by: Shona Robison 2 November 2016
Sativex is currently licensed to treat patients with moderate to severe spasticity due to Multiple Sclerosis. In Scotland, the Scottish Medicines Consortium (SMC) provides advice to NHS Scotland on the clinical and cost effectiveness of all new medicines. They do this following submissions made by the manufacturer. For Sativex, whilst the manufacturer does hold a product licence, they have not yet made a submission to the SMC to have Sativex considered for routine availability on the NHS in Scotland.